SEC Info - Chemours Co. - ‘8-K’ for 9/17/20

SEC Info℠

Home

Help

Please Sign In

Chemours Co. – ‘8-K’ for 9/17/20

On: Thursday, 9/17/20, at 4:24pm ET · For: 9/17/20 · Accession #: 1564590-20-43843 · File #: 1-36794

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/17/20  Chemours Co.                      8-K:8       9/17/20   10:161K                                   ActiveDisclosure/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     29K 
 6: R1          Document and Entity Information                     HTML     46K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 5: XML         XBRL Instance -- cc-8k_20200917_htm                  XML     14K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.LAB  XBRL Labels -- cc-20200917_lab                       XML     56K 
 4: EX-101.PRE  XBRL Presentations -- cc-20200917_pre                XML     34K 
 2: EX-101.SCH  XBRL Schema -- cc-20200917                           XSD     18K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
10: ZIP         XBRL Zipped Folder -- 0001564590-20-043843-xbrl      Zip     12K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C: C: C: C: C:

i false i 0001627223 0001627223 2020-09-17 2020-09-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM i 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

i September 17, 2020

Date of Report (Date of Earliest Event Reported)

i The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)

i Delaware	i 001-36794	i 46-4845564
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
Of Incorporation)	File Number)	Identification No.)

i 1007 Market Street

i Wilmington, i Delaware i 19801

(Address of principal executive offices)

Registrant’s telephone number, including area code: ( i 302) i 773-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol(s)		Name of Exchange on Which Registered
i Common Stock ($0.01 par value)		i CC		i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Item 8.01. Other Events.

On September 17, 2020, The Chemours Company (the “Company”) repaid the remaining $100 million of outstanding borrowings under its five-year, $800 million senior secured revolving credit facility (the “Facility”).

As previously disclosed in its Form 8-K filed with the Securities and Exchange Commission on April 3, 2020, the Company had borrowed $300 million under the Facility as a precautionary measure in light of macroeconomic uncertainties driven by the current novel coronavirus (“COVID-19”). The Company repaid $200 million of the outstanding borrowings on August 28, 2020, as previously disclosed in its Form 8-K filed with the Securities and Exchange Commission on August 31, 2020. Following the Company’s repayment of $100 million on September 17, 2020, no borrowings remain outstanding under the Facility.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


THE CHEMOURS COMPANY

By:		/s/ *Sameer Ralhan*
		Sameer Ralhan
		Senior Vice President, Chief Financial
		Officer

Date:		September 17, 2020

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	9/17/20
	8/31/20	8-K
	8/28/20	8-K
	4/3/20	8-K
		List all Filings

↑Top

Filing Submission 0001564590-20-043843 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)